taurine has been researched along with African Lymphoma in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Taurine was also shown to reduce significantly EC lysis mediated by lymphokine-activated killer (LAK) cells, while also significantly increasing tumor cytotoxicity." | 1.30 | Taurine attenuates recombinant interleukin-2-activated, lymphocyte-mediated endothelial cell injury. ( Bouchier-Hayes, DJ; Finnegan, NM; Redmond, HP, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Finnegan, NM | 1 |
| Redmond, HP | 1 |
| Bouchier-Hayes, DJ | 1 |
| Dallegri, F | 1 |
| Ottonello, L | 1 |
| Ballestrero, A | 1 |
| Ferrando, F | 1 |
| Patrone, F | 1 |
2 other studies available for taurine and African Lymphoma
| Article | Year |
|---|---|
Taurine attenuates recombinant interleukin-2-activated, lymphocyte-mediated endothelial cell injury.
Topics: Antineoplastic Agents; Blood; Burkitt Lymphoma; Calcium; Cell Line; Cytoplasmic Granules; Cytotoxici | 1998 |
Effector-target co-aggregation as a crucial step in the neutrophil-mediated tumour cell lysis.
Topics: Antibodies, Monoclonal; Antigens, Differentiation; Burkitt Lymphoma; Cell Aggregation; Cytotoxicity, | 1989 |